Literature DB >> 1951420

Mixed cryoglobulinemia responsive to interferon-alpha.

T A Knox, C D Hillyer, M M Kaplan, E M Berkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1951420     DOI： 10.1016/0002-9343(91)90196-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Fatal exacerbation of hepatitis C-related cryoglobulinemia with interferon-alpha therapy.

Authors:  G Friedman; S Mehta; A H Sherker
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  Hepatitis C: a possible etiology for cryoglobulinaemia type II.

Authors:  A Pechère-Bertschi; L Perrin; P de Saussure; J J Widmann; E Giostra; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Is interferon alpha 2b effective on cryoglobulinaemia related to hepatitis C virus?

Authors:  B Taillan; E Ferrari; A Pesce; G Garnier; H Vinti; J G Fuzibet; P Dujardin
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

4.  Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection.

Authors:  J M Durand; E Cretel; G Kaplanski; P Lefevre; F Retornaz; J Soubeyrand
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

5.  Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges.

Authors:  L Guillevin; F Lhote; F Sauvaget; P Deblois; F Rossi; D Levallois; J Pourrat; B Christoforov; C Trépo
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

6.  Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a.

Authors:  I Bojić; D Lilić; C Radojcić; P Mijusković
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

7.  Neutrophil-generated free radicals: possible mechanisms of injury in adult respiratory distress syndrome.

Authors:  J M McCord; B Gao; J Leff; S C Flores
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.